Radiopharm Theranostics Limited
- RADX
- NASDAQ
- Biotechnology
- Radiopharmaceuticals
- Theranostics (Diagnostics/Therapeutics)
- Oncology
$0.96
Today −6.50%Quote Oct 19, 2026, 07:12 PM UTC
−40.46%over the last month
Max drawdown −40.5%From 1-month high −40.5%3 months −75.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Radiopharm Theranostics
Radiopharm Theranostics Limited, an Australian company established in Carlton in 2021, specializes in the research and development of cutting-edge radiopharmaceutical treatments. Their mission is to address critical gaps in healthcare by creating products for both diagnostic imaging and therapeutic intervention across a spectrum of challenging medical conditions.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
14
Market value
$3.41B
Quote Oct 19
Analyst target
$6.00
+523.1% from here
Floor
$0.95
1.0% below price
Resistance
$1.00
3.8% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about RADXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free